Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1365

1.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
2.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
3.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
4.

Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment.

Delbeke D, Pinson CW.

J Hepatobiliary Pancreat Surg. 2004;11(1):4-10. Review.

PMID:
15747028
5.

Positron emission tomography for prostate, bladder, and renal cancer.

Schöder H, Larson SM.

Semin Nucl Med. 2004 Oct;34(4):274-92. Review.

PMID:
15493005
6.

Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.

Pery C, Meurette G, Ansquer C, Frampas E, Regenet N.

Gastroenterol Clin Biol. 2010 Sep;34(8-9):465-74. doi: 10.1016/j.gcb.2009.04.014. Epub 2010 Aug 4. Review.

7.

Role of positron emission tomography in the (re-)staging of oesophageal cancer.

Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ.

Scand J Gastroenterol Suppl. 2006;(243):116-22. Review.

PMID:
16782630
8.

Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.

Sathekge M, Maes A, D'Asseler Y, Vorster M, Van de Wiele C.

Nucl Med Commun. 2012 Jun;33(6):581-90. doi: 10.1097/MNM.0b013e3283528a7c. Review.

PMID:
22422098
9.

FDG PET-CT in the management of primary breast lymphoma.

Santra A, Kumar R, Reddy R, Halanaik D, Kumar R, Bal CS, Malhotra A.

Clin Nucl Med. 2009 Dec;34(12):848-53. doi: 10.1097/RLU.0b013e3181becdfc. Review.

PMID:
20139815
10.

18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.

Wu LM, Chen FY, Jiang XX, Gu HY, Yin Y, Xu JR.

Eur J Radiol. 2012 Feb;81(2):303-11. doi: 10.1016/j.ejrad.2010.11.020. Epub 2010 Dec 9. Review.

PMID:
21145680
11.

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.

Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD.

Ann Surg. 1999 May;229(5):729-37; discussion 737-8. Review.

12.

Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis.

Rijkers AP, Valkema R, Duivenvoorden HJ, van Eijck CH.

Eur J Surg Oncol. 2014 Jul;40(7):794-804. doi: 10.1016/j.ejso.2014.03.016. Epub 2014 Apr 3. Review.

PMID:
24755095
13.

A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.

Qu X, Huang X, Yan W, Wu L, Dai K.

Eur J Radiol. 2012 May;81(5):1007-15. doi: 10.1016/j.ejrad.2011.01.126. Epub 2011 Feb 26. Review.

PMID:
21354739
14.

What is the best way to diagnose and stage malignant pleural mesothelioma?

Zahid I, Sharif S, Routledge T, Scarci M.

Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):254-9. doi: 10.1510/icvts.2010.255893. Epub 2010 Nov 1. Review.

15.

Role of positron emission tomography in urological oncology.

Rioja J, Rodríguez-Fraile M, Lima-Favaretto R, Rincón-Mayans A, Peñuelas-Sánchez I, Zudaire-Bergera JJ, Parra RO.

BJU Int. 2010 Dec;106(11):1578-93. doi: 10.1111/j.1464-410X.2010.09510.x. Review.

16.

Established, emerging and future applications of FDG-PET/CT in the uterine cancer.

Kitajima K, Murakami K, Kaji Y, Sakamoto S, Sugimura K.

Clin Radiol. 2011 Apr;66(4):297-307. doi: 10.1016/j.crad.2010.07.012. Epub 2011 Jan 14. Review.

PMID:
21356392
17.

Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.

Chen Z, Li X, Li F, Ouyang Q, Yu T.

Eur J Radiol. 2010 Sep;75(3):329-35. doi: 10.1016/j.ejrad.2010.05.039. Epub 2010 Jun 23. Review.

PMID:
20576385
18.

[18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.

Chowdhury FU, Shah N, Scarsbrook AF, Bradley KM.

Postgrad Med J. 2010 Mar;86(1013):174-82. doi: 10.1136/pgmj.2009.079087. Review.

PMID:
20237012
19.

[Hybrid PET/CT in cancer imaging].

Seppänen M, Kajander S, Kemppainen J, Minn H.

Duodecim. 2011;127(11):1117-27. Review. Finnish.

PMID:
21755803
20.

FDG-PET/CT in lung cancer: an update.

Baum RP, Swietaszczyk C, Prasad V.

Front Radiat Ther Oncol. 2010;42:15-45. doi: 10.1159/000262458. Epub 2009 Nov 24. Review.

PMID:
19955789
Items per page

Supplemental Content

Write to the Help Desk